Signatope

Drug Discovery

Overview

Immunoassays for any Protein, any Specimen and any Species. SIGNATOPE offers next generation quantitative assays for your protein biomarker of interest!

Funding and backers

Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
CytorumVenture round $150k · 4 yr ago · Founded 2020 · 11-50 employees
We provide next generation fluorescence, spectral, and mass cytometry services. Project design, wet lab assay development, and advanced…
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
GateBioscienceFounded 2021 · 11-50 employees
Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that…
Khumbu.aiVenture round · 18 mo ago · Founded 2024 · 51-200 employees
AI-first biotech accelerating early drug discovery with protein–ligand insights and advanced models for molecular understanding. Khumbu.ai.
PsileraSeed $8.8M · 5 mo ago · Founded 2021 · 11-50 employees
Psilera is a biotechnology company developing groundbreaking first-in-class treatments for neurological disorders by creating a new class…
0 About Us AAX Biotech AB is a research-driven biotech company with proprietary technologies that solve unmet needs in the development of…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
516 portfolio companies